Skip to main content
Veterinary Medicines

CYCLIO 30 MG SPOT-ON SOLUTION FOR MEDIUM SIZED DOGS

Authorised
  • Pyriproxyfen

Product identification

Medicine name:
CYCLIO 30 MG SPOT-ON SOLUTION FOR MEDIUM SIZED DOGS
Cyclio 30 mg Lösung zum Auftropfen für mittelgroße Hunde
Active substance:
  • Pyriproxyfen
Target species:
  • Dog
Route of administration:
  • Cutaneous use

Product details

Active substance and strength:
  • Pyriproxyfen
    30.00
    milligram(s)
    /
    1.00
    Pipette
Pharmaceutical form:
  • Spot-on solution
Withdrawal period by route of administration:
  • Cutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AX23
Authorisation status:
  • Valid
Authorised in:
  • Austria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
  • Virbac
Responsible authority:
  • Austrian Agency For Health And Food Safety
Authorisation number:
  • 8-00466
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0114/003
Concerned member states:
  • Austria
  • Denmark
  • Germany
  • Ireland
  • Italy
  • Luxembourg
  • Netherlands

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 1/10/2013

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 11/10/2017

Labelling

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 1/10/2013
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."